Randomized trial demonstrates improved classification of early diabetic retinopathy through multimodal fusion, suggesting enhanced diagnostic capabilities.
Early detection of diabetic retinopathy (DR) is crucial for preventing irreversible vision loss; however, existing automated methods often rely on single-modality inputs, thereby limiting the complementary diagnostic value of multimodal imaging. This study presents a cross-attention-based multimodal fusion framework that investigates cross-attention-based representation learning using semantically aligned fundus photography and OCT datasets for the classification of early-stage diabetic retinopathy (E-DR). The proposed architecture utilises EfficientNetB0 and DenseNet121 as modality-specific encoders, followed by a mid-level cross-attention module that dynamically aligns and fuses vascular and structural features. To enable consistent multimodal training, we develop a harmonised label-mapping strategy and a balanced dataset construction pipeline. Extensive experiments across unimodal and fused configurations demonstrate that our fusion model significantly outperforms baseline models, achieving an overall accuracy of 96% and notable improvements in early-stage detection (e.g., F1-score of 83% for Stage 1), comparing to the previous fusion state-of-the-art works that rely on simple concatenation or late-stage integration, our proposed fusion model captures richer cross-modal feature interactions, resulting in improved classification performance on the evaluated datasets. This study provides an exploratory investigation of cross-attention-guided multimodal fusion for retinal image analysis for early DR diagnosis and other ophthalmic screening assessments.
No takes yet. Share an insight, caveat, or question.
Bhutto et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: